OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Acquired Factor V Inhibitor after Coronavirus Disease 2019 (COVID-19)
Federico Chiurazzi, Antonella Tufano, Maria Esposito, et al.
Seminars in Thrombosis and Hemostasis (2021) Vol. 48, Iss. 01, pp. 124-126
Open Access | Times Cited: 7
Federico Chiurazzi, Antonella Tufano, Maria Esposito, et al.
Seminars in Thrombosis and Hemostasis (2021) Vol. 48, Iss. 01, pp. 124-126
Open Access | Times Cited: 7
Showing 7 citing articles:
A First Case Report of Autoimmune Acquired Factor V Deficiency After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination at the Time of Initiating Haemodialysis
Ayako Tasaki, Akihiro Fukuda, Akiko Kudo, et al.
Nephrology (2025) Vol. 30, Iss. 2
Open Access
Ayako Tasaki, Akihiro Fukuda, Akiko Kudo, et al.
Nephrology (2025) Vol. 30, Iss. 2
Open Access
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part III
Emmanuel J. Favaloro, Giuseppe Lippi
Seminars in Thrombosis and Hemostasis (2022) Vol. 48, Iss. 01, pp. 003-007
Open Access | Times Cited: 20
Emmanuel J. Favaloro, Giuseppe Lippi
Seminars in Thrombosis and Hemostasis (2022) Vol. 48, Iss. 01, pp. 003-007
Open Access | Times Cited: 20
Autoimmune Diseases Affecting Hemostasis: A Narrative Review
Emmanuel J. Favaloro, Leonardo Pasalic, Giuseppe Lippi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14715-14715
Open Access | Times Cited: 11
Emmanuel J. Favaloro, Leonardo Pasalic, Giuseppe Lippi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14715-14715
Open Access | Times Cited: 11
Coagulation factor inhibitors in COVID‐19: From SARS‐CoV‐2 vaccination to infection
Jeremy W. Jacobs, Brian D. Adkins, Shannon C. Walker, et al.
Research and Practice in Thrombosis and Haemostasis (2022) Vol. 6, Iss. 3, pp. e12700-e12700
Open Access | Times Cited: 9
Jeremy W. Jacobs, Brian D. Adkins, Shannon C. Walker, et al.
Research and Practice in Thrombosis and Haemostasis (2022) Vol. 6, Iss. 3, pp. e12700-e12700
Open Access | Times Cited: 9
Delayed spontaneous remission of acquired factor V inhibitor refractory to immunosuppressive therapy with pregnancy-associated improvement
Andrea Ceglédi, János Dolgos, Mónika Fekete, et al.
Pathology & Oncology Research (2023) Vol. 29
Open Access | Times Cited: 2
Andrea Ceglédi, János Dolgos, Mónika Fekete, et al.
Pathology & Oncology Research (2023) Vol. 29
Open Access | Times Cited: 2
Acquired factor V inhibitor with erythema and eosinophilia in a patient with end-stage renal disease
Eisuke Katsuren, Kentaro Kohagura, Takanori Kinjyo, et al.
CEN Case Reports (2022) Vol. 12, Iss. 1, pp. 91-97
Open Access | Times Cited: 4
Eisuke Katsuren, Kentaro Kohagura, Takanori Kinjyo, et al.
CEN Case Reports (2022) Vol. 12, Iss. 1, pp. 91-97
Open Access | Times Cited: 4
Acquired factor V inhibitor treated with rituximab
Faisal Ansari, Yurhee Lee, Umme Ammara Maqbool Ahmad Ansari, et al.
BMJ Case Reports (2024) Vol. 17, Iss. 11, pp. e256475-e256475
Closed Access
Faisal Ansari, Yurhee Lee, Umme Ammara Maqbool Ahmad Ansari, et al.
BMJ Case Reports (2024) Vol. 17, Iss. 11, pp. e256475-e256475
Closed Access
